XML 30 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Supplemental Disclosure of Cash Flow Information
 9 Months Ended
Sep. 30, 2020
Supplemental Cash Flow Elements [Abstract]  
Supplemental Disclosure of Cash Flow Information Supplemental Disclosure of Cash Flow Information
Nine Months Ended
September 30,
(in thousands)20202019
Supplemental Disclosure of Cash Flow Information:
Interest paid$157,688 $185,722 
Income taxes paid, net of refunds4,236 1,909 
Capital expenditures, net of related payables:
Capital expenditures - non-development, net$104,949 $180,187 
Capital expenditures - development, net9,913 18,677 
Capital expenditures - non-development - reimbursable17,979 12,043 
Trade accounts payable7,849 (4,522)
Net cash paid$140,690 $206,385 
Acquisition of communities from Healthpeak:
Property, plant and equipment and leasehold intangibles, net$286,734 $— 
Operating lease right-of-use assets(63,285)— 
Financing lease obligations129,196 — 
Operating lease obligations74,335 — 
Loss (gain) on debt modification and extinguishment, net(19,731)— 
Net cash paid$407,249 $— 
Master Agreement with Ventas:
Property, plant and equipment and leasehold intangibles, net$(66,444)$— 
Operating lease right-of-use assets(153,213)— 
Other assets, net(42,354)— 
Long-term debt34,053 — 
Financing lease obligations7,077 — 
Operating lease obligations362,944 — 
Additional paid-in-capital(22,883)— 
Net cash paid$119,180 $— 
Acquisition of other assets, net of related payables and cash received:
Property, plant and equipment and leasehold intangibles, net$684 $— 
Other intangible assets, net— 453 
Financing lease obligations64,260 — 
Net cash paid$64,944 $453 
Proceeds from sale of CCRC Venture, net:
Investments in unconsolidated ventures$(14,848)$— 
Current portion of long-term debt34,706 — 
Other liabilities60,748 — 
Loss (gain) on sale of assets, net(369,831)— 
Net cash received$(289,225)$— 
Proceeds from sale of other assets, net:
Prepaid expenses and other assets, net$(1,318)$(5,298)
Assets held for sale(34,348)(41,882)
Property, plant and equipment and leasehold intangibles, net(938)(647)
Investments in unconsolidated ventures— (156)
Other liabilities(1,086)(2,724)
Loss (gain) on sale of assets, net(4,188)(2,723)
Net cash received$(41,878)$(53,430)
Supplemental Schedule of Non-cash Operating, Investing, and Financing Activities:
Assets designated as held for sale:
Prepaid expenses and other assets, net$— $(5)
Assets held for sale— 9,169 
Property, plant and equipment and leasehold intangibles, net— (9,164)
Net$— $— 
Healthpeak master lease modification:
Property, plant and equipment and leasehold intangibles, net$(57,462)$— 
Operating lease right-of-use assets88,044 — 
Financing lease obligations70,874 — 
Operating lease obligations(101,456)— 
Net$— $— 
Other lease termination and modification, net:
Prepaid expenses and other assets, net$— $(648)
Property, plant and equipment and leasehold intangibles, net13,498 (1,666)
Operating lease right-of-use assets7,291 (8,644)
Financing lease obligations(15,483)— 
Operating lease obligations(5,199)9,289 
Other liabilities(107)(337)
Loss (gain) on facility lease termination and modification, net— 2,006 
Net$— $— 
During the three months ended June 30, 2019, the Company and its joint venture partner contributed cash in an aggregate amount of $13.3 million to a consolidated joint venture which owned three senior housing communities. The Company obtained a $6.6 million promissory note receivable from its joint venture partner secured by a 50% equity interest in the joint venture in a non-cash exchange for the Company funding the $13.3 million aggregate contribution in cash.

Restricted cash consists principally of deposits for letters of credit, escrow deposits for real estate taxes, property insurance, and capital expenditures, debt service reserve accounts required by certain lenders under mortgage debt agreements, and deposits as security for self-insured retention risk under workers' compensation programs and property insurance programs. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sums to the total of the same such amounts shown in the condensed consolidated statements of cash flows.
(in thousands)September 30, 2020December 31, 2019
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents$354,621 $240,227 
Restricted cash35,206 26,856 
Long-term restricted cash103,248 34,614 
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows$493,075 $301,697